S'pore's biomedical industry a success<\/p>\n
Agence France-Presse, Singapore<\/p>\n
Singapore is becoming a successful international biomedical
\nhub more quickly than planned, the government said Wednesday as
\nGlaxoSmithKline announced an expansion of its operations in the
\ncity-state.<\/p>\n
Trade Minister George Yeo said the industry's output for this
\nyear would likely hit 12 billion Singapore dollars (seven billion
\nUS), 12 months ahead of schedule and double the 2000 figure.<\/p>\n
\"In the last three years, Singapore's efforts in the
\nbiomedical sciences have yielded better results than what we
\ncould have reasonably expected,\" Yeo said at a press conference
\nto open an expanded GlaxoSmithKline facility.<\/p>\n
\"We (have) achieved a certain reputation in the international
\nbiomedical community for our openness to new ideas and our
\nwillingess to try new things.<\/p>\n
\"The Biopolis (biomedical industrial park), which opened in
\nOctober last year, has become the hub for biomedical research.\"<\/p>\n
GlaxoSmithKline, the UK-headquartered multinational
\npharmaceutical company, has been one of the biggest firms
\nattracted to Singapore's biomedical facilities.<\/p>\n
On Wednesday it announced the completion of a 100-million-
\ndollar expansion of its manufacturing facility in Singapore and
\nsaid it planned to invest another 50 million dollars to develop a
\ntechnology center.<\/p>\n
The expanded manufacturing facility will provide increased
\ncapacity to make more fluticasone propionate, a compound used to
\nproduce GlaxoSmithKline's portfolio of respiratory medicines,
\nsuch as Seretide, Flixotide and Flixonase.<\/p>\n
GlaxoSmithKline, which has invested more than one billion
\ndollars in Singapore and employs 600 people here, hopes to
\ncomplete the proposed technology center by late next year.<\/p>",
"url": "https:\/\/jawawa.id\/newsitem\/spores-biomedical-industry-a-success-1447893297",
"image": ""
},
"sponsor": "Okusi Associates",
"sponsor_url": "https:\/\/okusiassociates.com"
}